Asynchronous telehealth in 2026: what you can prescribe without a video visit
Most of the economics in direct-to-consumer care come from the async visit: a structured intake, a clinician review, a prescription — no calendar. Whether that is lawful depends on the state, the drug, and how the intake is built.
Lithos StaffAsynchronous (store-and-forward) telehealth is lawful in most states for establishing a patient relationship and prescribing non-controlled medications, provided the intake collects what a standard of care requires and a licensed clinician reviews it. A minority of states require a synchronous (audio-video or, sometimes, audio) encounter before prescribing, and a few restrict questionnaire-only prescribing specifically. Controlled substances sit under federal telemedicine rules that currently require a real-time interaction in most cases. Build your intake as a clinical instrument, route by state modality rules, and escalate to a live visit automatically when the answers call for it.
What async actually means
Asynchronous telehealth replaces the appointment with an artifact. The patient completes a structured medical intake — history, medications, allergies, symptoms, photos, vitals, sometimes lab results — and a licensed clinician reviews it later, asks clarifying questions through secure messaging, and makes a decision. No scheduling, no no-shows, and a clinician who can review a dozen well-built intakes in the time one video visit takes.
That efficiency is exactly why regulators look at it closely. The question a board asks is not “was there a video call?” but “did the clinician have enough information to meet the standard of care?” An async program that answers yes, with documentation, is on solid ground. One that treats the questionnaire as a checkout form is not.
The three layers of rules
- State modality rules. Each state defines what counts as telehealth and which modalities can establish a patient relationship. Most accept store-and-forward for non-controlled prescribing; a minority require a synchronous first encounter; several specifically restrict prescribing on the basis of an online questionnaire alone. See telehealth modality laws.
- Federal controlled-substance rules. The Ryan Haight Act and the DEA’s telemedicine framework govern scheduled drugs nationwide. The current flexibilities and the special-registration framework are built around real-time encounters; see the 2026 DEA map.
- Standard of care. Independent of modality, the clinician must gather what a reasonable clinician would gather before prescribing this drug to this patient. For some products that means labs; for some it means a photo; for some it means a conversation.
What is commonly async-eligible, and what is not
| Category | Async posture | Watch for |
|---|---|---|
| Hair loss, skin, acne | Async-first almost everywhere | Photo quality standards; isotretinoin-class exceptions |
| Sexual health (ED, PE) | Async-first in most states | Cardiac history screening; nitrate interactions |
| GLP-1 weight care | Async-eligible for non-controlled agents | Baseline labs, BMI documentation, contraindication screening |
| Hormone therapy (HRT) | Async for many estrogen/progesterone regimens | Labs before and during; state variation |
| Testosterone (TRT) | Synchronous — Schedule III | Federal telemedicine rules; state add-ons |
| ADHD, sleep (controlled) | Synchronous | Schedule II–IV rules; some states forbid entirely |
| Primary-care refills | Async once the relationship exists | Whether the relationship was validly established first |
Designing an intake that holds up
- Treat it as a clinical instrument. Every question maps to a clinical decision: eligibility, contraindication, dosing, escalation. If a question does not change what the clinician does, cut it.
- Branch, don’t list. A reported cardiac history should open follow-up questions, not sit in a text box.
- Escalate automatically. Certain answers, states, or products should route the patient into a synchronous visit without the clinician having to remember.
- Verify identity. Identity proofing is part of what makes an async relationship valid, and several states require it explicitly.
- Capture consent. Telehealth informed consent, in the form each state prescribes, before the review.
- Document the review. The clinician’s note should show what was considered, not just what was prescribed. This is what a board reads.
Routing by state
The practical architecture is a rules layer between intake and clinician: patient state plus product plus intake answers decide whether the case goes to an async queue, requires a live visit, or is ineligible. Programs that hard-code this in the front-end break the first time a legislature changes a rule; programs that treat it as configurable infrastructure update a table.
Frequently asked questions
What is asynchronous telehealth?
Care delivered without the patient and clinician interacting in real time. The patient completes a structured medical intake (history, symptoms, photos, sometimes labs); a licensed clinician reviews it later, asks follow-up questions if needed, and makes a treatment decision. It is also called store-and-forward telehealth.
Is it legal to prescribe from a questionnaire alone?
In many states, yes, if the questionnaire is a genuine medical evaluation that meets the standard of care and a licensed clinician reviews it before prescribing. Some states require a synchronous visit to establish the relationship, and several explicitly prohibit prescribing based solely on an online questionnaire. Modality rules must be checked per state.
Can controlled substances be prescribed asynchronously?
Generally no. Federal telemedicine prescribing rules for controlled substances are built around real-time audio-video encounters (with limited exceptions), and many states add their own restrictions. Programs prescribing testosterone, stimulants, or other scheduled drugs should plan on synchronous visits for those patients.
Which verticals work best async-first?
Hair loss, skin care, sexual health, GLP-1 weight care (non-controlled), and many primary-care refills. Programs involving controlled substances, complex chronic disease, or pediatric patients typically need a synchronous component.
From first call to first patient, in weeks.
A 15-minute intro call, sandbox credentials the same day, go-live in 3–4 weeks — new launches and existing patient bases alike.